Provider
upcoming-policies-effective-january-30-2023.pdf
Documents & Forms Results
Displaying 821 - 830 of 3754 results
Provider
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Program effective Date: Nov 23, 2022
Provider
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Program effective Date: Nov 23, 2022
Provider
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Program effective Date: Nov 23, 2022
Provider
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Program effective Date: Nov 23, 2022
Provider
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Program effective Date: Feb 01, 2023
Provider
QP112R1-20 Changes to Electronic Funds Transfer Processes
Program effective Date: Feb 22, 2023
Provider
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Program effective Date: Feb 22, 2023
Provider
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Program effective Date: Feb 22, 2023